Loki Zupa alleviates type 2-high acute asthma airway inflammation by regulating the glutathione metabolism-ferroptosis axis
Phytomedicine · 2026-10 · 160 · 158672
DOI: 10.1016/j.phymed.2026.158672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-10. Verfasst von Huijie Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, China; Department of Integrative Medicine, Huashan Hospital, F…. Hauptthemen laut MEDLINE: Glutathione, Asthma, Drugs, Chinese Herbal, Ferroptosis. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Technical Project.
Abstract (Originalsprache)
BACKGROUND: Oxidative stress-induced disruption of glutathione metabolism triggers ferroptosis in airway epithelial cells, thereby exacerbating type 2-high acute asthma. Loki Zupa (LKZP) is a classic Uyghur formula used for asthma with confirmed anti-inflammatory and antioxidant effects, but its mechanism via the glutathione-ferroptosis axis remains unclear. PURPOSE: This study aimed to characterize LKZP's efficacy against type 2-high acute asthma and to elucidate its mechanism, focusing on the glutathione metabolism-ferroptosis axis. METHODS: An OVA-induced type 2-high acute asthma mouse model was established to evaluate the anti-inflammatory and antioxidant effects of LKZP. UHPLCHRMS was used to identify its active components, and network pharmacology combined with proteomics and metabolomics was applied to predict the underlying mechanisms. An RSL3-induced ferroptosis cell model was employed to verify LKZP's protective effects on cell viability, glutathione (GSH) and malondialdehyde (MDA) levels, as well as the expression of ferroptosis-related proteins. Molecular docking and surface plasmon resonance (SPR) assay were performed to collectively evaluated the binding affinity between Linarin (an active component of LKZP) and GSTM1/GSTM2. RESULTS: LKZP significantly alleviated airway inflammation and oxidative stress injury in asthmatic mice. Its anti-asthmatic effect was linked to the glutathione metabolism-ferroptosis axis. In vivo and in vitro experiments confirmed that LKZP restored glutathione metabolic homeostasis, scavenged excessive reactive oxygen species (ROS), reduced iron overload and lipid peroxidation, and inhibited ferroptosis in lung tissue and airway epithelial cells. Molecular docking and molecular dynamics simulation predicted stable binding of Linarin to GSTM1 and GSTM2. SPR analysis further confirmed these interactions and demonstrated a higher binding affinity of Linarin toward GSTM1 than GSTM2. CONCLUSION: LKZP alleviated airway inflammation and oxidative stress in type 2-high acute asthma by regulating the glutathione metabolism-ferroptosis axis, providing novel mechanistic insights for its asthma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, China; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Integrative Medicine,…
- Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
- Department of Traditional Chinese Medicine, Children's Hospital of Fudan University, Shanghai, 201102, PR China.
- Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, China; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
- Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Integrative Medicine, Fudan University, Shanghai, China; Kashi BGI South Xinjiang Precision Medicine Laboratory, Kas…
- Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- Shenzhen Technical Project
Zitieren
APA
Zhang, H., Tang, W., Wang, N., Chen, M., Yalikun, M., Weng, Q., Yang, K., Chen, W., Yang, F., He, J., Zheng, Q., Wei, Y., Gao, Z., Dong, J., & Wang, S. (2026). Loki Zupa alleviates type 2-high acute asthma airway inflammation by regulating the glutathione metabolism-ferroptosis axis. Phytomedicine, 160, 158672. https://doi.org/10.1016/j.phymed.2026.158672
Vancouver
Zhang H, Tang W, Wang N, Chen M, Yalikun M, Weng Q, et al. Loki Zupa alleviates type 2-high acute asthma airway inflammation by regulating the glutathione metabolism-ferroptosis axis. Phytomedicine. 2026;160:158672. doi:10.1016/j.phymed.2026.158672
BibTeX
@article{Zhang2026,
author = {Zhang, Huijie and Tang, Weifeng and Wang, Na and Chen, Mengmeng and Yalikun, Maimaititusun and Weng, Qian and Yang, Kai and Chen, Wenjing and Yang, Fangyong and He, Jiemin and Zheng, Qiaoqi and Wei, Ying and Gao, Zhen and Dong, Jingcheng and Wang, Shiyuan},
title = {Loki Zupa alleviates type 2-high acute asthma airway inflammation by regulating the glutathione metabolism-ferroptosis axis},
journal = {Phytomedicine},
year = {2026},
volume = {160},
pages = {158672},
doi = {10.1016/j.phymed.2026.158672}
}
EUVIMED